Trials / Completed
CompletedNCT05872178
Omegia Softgel Clinical Research Program
Chia Nan University of Pharmacy & Science
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Chia Nan University of Pharmacy & Science · Academic / Other
- Sex
- Female
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the improvement of regulation of skin and blood index composition after consumption of Omegia® Softgel
Detailed description
The blood biochemical analysis at Weeks 0 and 12, including Catalase, Tumor necrosis factor-α, Cholesterol, Triglyceride, High-density lipoprotein-Cholesterol and Low-density lipoprotein- Cholesterol. The Skin assessment at Weeks 0, 4 and 12, including Skin brightness, Skin redness sensitivity index, Skin moisture, Skin elasticity, Facial skin pores, Facial skin texture and Skin collagen content.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omegia® Softgel -B | How to use: Take once a day for 12 weeks Subject precautions: If the health products and cosmetic care products used contain sea buckthorn ingredients, stop using them. |
| DIETARY_SUPPLEMENT | Omegia® Softgel -A | How to use: Take once a day for 12 weeks Subject precautions: If the health products and cosmetic care products used contain sea buckthorn ingredients, stop using them. |
Timeline
- Start date
- 2021-04-15
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2023-05-24
- Last updated
- 2023-05-24
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05872178. Inclusion in this directory is not an endorsement.